Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Ba50192817e76cb6fc1aab63078c7ca16> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Ba50192817e76cb6fc1aab63078c7ca16 NCIT_P378 "NCI" @default.
- Ba50192817e76cb6fc1aab63078c7ca16 type Axiom @default.
- Ba50192817e76cb6fc1aab63078c7ca16 annotatedProperty IAO_0000115 @default.
- Ba50192817e76cb6fc1aab63078c7ca16 annotatedSource NCIT_C172993 @default.
- Ba50192817e76cb6fc1aab63078c7ca16 annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with afatinib in patients with tumors that have activating ERBB2 (HER2) gene mutations, excluding non-small cell lung carcinoma." @default.